Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126666) titled 'Real-World Study of Onradivir Tablets in Patients with Influenza A Virus Infection' on June 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Condition:
Influenza A virus infection
Intervention:
baloxavir marboxil:Baloxavir Marboxil, 40-80mg/dose, taken orally once
Short-course Onradivir Tablets versus:Onradivir Tablets, 0.6g per dose, once daily, for 3 consecutive days
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-06-30
Target Sample Size: baloxavir marboxil:800;Short-course Onradiv...